Reverse Medical is a commercial-stage medical device company founded in 2007 and headquartered in the United States. The company is dedicated to restoring blood flow in patients with Acute Ischemic Stroke. Specializing in revascularizing patients experiencing this condition, Reverse Medical operates in the Biotechnology and Pharmaceutical industries. Notably, the company secured a significant $14.00M Series B investment on 07 April 2010. This investment round saw involvement from several prominent investors such as Early Stage Partners, Emergent Medical Partners, BioStar Capital, MedFocus Fund, Wexford Capital, and NBGI Ventures. The company's commitment to addressing a critical need in the medical field and the substantial backing it has received make it a compelling prospect for potential investors.
No recent news or press coverage available for Reverse Medical Corporation.